Terms: = Liver cancer AND NF2, ACN, 4771, ENSG00000186575, P35240, SCH, Merlin, BANF AND Diagnosis
4 results:
1. The Identification and Analysis of MicroRNAs Combined Biomarkers for Hepatocellular Carcinoma diagnosis.
Shi Y; Men J; Sun H; Tan J
Med Chem; 2022; 18(10):1073-1085. PubMed ID: 35379158
[TBL] [Abstract] [Full Text] [Related]
2. Hepatic sclerosed hemangioma and sclerosing cavernous hemangioma: a radiological study.
Jia C; Liu G; Wang X; Zhao D; Li R; Li H
Jpn J Radiol; 2021 Nov; 39(11):1059-1068. PubMed ID: 34041675
[TBL] [Abstract] [Full Text] [Related]
3. Normal tissue adjacent to tumor expression profile analysis developed and validated a prognostic model based on Hippo-related genes in hepatocellular carcinoma.
Pan Q; Qin F; Yuan H; He B; Yang N; Zhang Y; Ren H; Zeng Y
Cancer Med; 2021 May; 10(9):3139-3152. PubMed ID: 33818013
[TBL] [Abstract] [Full Text] [Related]
4. Hepatic sclerosing cavernous haemangioma can mimic the nodular elastosis stage of segmental atrophy.
Findeis-Hosey JJ; Zhou Z; Gonzalez RS
Histopathology; 2019 Dec; 75(6):876-881. PubMed ID: 31356680
[TBL] [Abstract] [Full Text] [Related]
